Table of Content
Summary
Convertible notes are debt with a conversion hook
They're promissory notes that convert to equity when a Series A closes, not a shortcut to raising capital faster. Interest accrues, maturity dates apply, repayment is possible.
[01]
SAFEs have replaced convertible notes in pre-seed
90% of pre-seed deals use SAFEs now. Convertible notes work for bridge rounds, international raises, and revenue-generating companies that want debt-style structure.
[02]
Valuation caps and discounts cost founders real dilution
A $3M cap versus a $5M cap creates 10-15% more founder dilution at Series A. Negotiate these upfront with the noteholder, not at Series A diligence.
[03]
Multiple convertible notes create cap table nightmares
Each note has its own cap and discount. When all three convert at Series A at different terms, the aggregate dilution surprises most founders. Model it before signing.
[04]
Maturity dates are the time bomb founders ignore
If a Series A doesn't close by the maturity date, you owe the principal back. Most founders don't have the cash. Plan the extension or refinancing conversation early.
[05]
A founder walked into our advisory call last Tuesday. He told me he had a convertible note term sheet from a strategic investor and had already verbally agreed. Cap was four million, the discount sat at twenty-five percent, interest at eight percent, maturity at eighteen months.
I've worked on convertible notes for more than 200 founders in the last five years. The odd pattern I see: most founders treat them like they're synonymous with SAFEs.
They're not. That confusion costs founders real equity.
Convertible notes are debt instruments that defer the valuation question. They're not equity yet, but rather a promissory note with a maturity date, an interest rate, and a trigger event that converts them into stock when certain conditions hit.
The investor gets downside protection through terms like valuation caps and discount rates.
The founder gets to raise capital without negotiating valuation.
See how this compares to priced equity rounds options.
But here's where most founders get it wrong: convertible notes are debt with conversion mechanics, not a shortcut to raising capital faster. They come with all the complexity of debt, maturity dates, interest accrual, potential repayment obligations, plus the cap table chaos of conversion.
In 2026, when SAFEs dominate pre-seed fundraising (90% of pre-seed deals use SAFEs, not convertible notes), the decision to raise a convertible note needs to be deliberate, not default.
What is a convertible note?
A convertible note is a short-term debt instrument that converts into equity when a triggering event occurs, usually a Series A or other qualifying funding round. The investor loans the company money. The company promises to repay it, but with a twist: if a specific event happens (typically a priced equity round), the debt automatically converts into stock at a discount to the priced round's valuation.
The mechanics matter because they shape the founder's cap table surprise.
The investor gets:
A debt security with a maturity date
An interest accrual that either gets paid out or added to the principal at conversion
Downside protection through a valuation cap (the maximum valuation the note converts at)
And optionally a discount (a percentage discount to the Series A price).
The founder gets: capital without a valuation negotiation, a clear legal document, and clarity that this is not equity yet.
Sounds simple. It's not.
How convertible notes work, from investment to conversion.
The timeline is where most founders trip up.
Month 1: You raise a $150K convertible note from a lead investor. You get the money in the bank. Legal costs run $2K-$5K.
Months 2-12: You're building, growing, fundraising. The note sits dormant. Interest accrues silently.
Month 18: You're building traction and start Series A conversations.
Month 24: A VC commits $2M at $10M post-money valuation and the term sheet is signed.
Month 25-26: Diligence begins. The VC looks at your cap table, sees the note, and asks about terms, conversion timing, and the cap.
The VC now run their own conversion math. They see how much dilution the note creates. If the cap is aggressive (low), the note converts to many shares, and the VC's ownership is diluted more than expected.
Month 26: Your noteholder's lawyer reviews Series A terms and confirms conversion math. The note converts automatically.
Month 27: Post-closing, you have 3 new shareholders:
The noteholder
The Series A lead
Potentially other Series A investors.
Your cap table is now more complex.
Conversion happens automatically. No additional vote needed. The noteholder's lawyer gets the final numbers, and the conversion is finalised in the cap table amendment.
But here's what most founders don't think about: if your Series A doesn't close, the maturity date becomes your problem. You now owe debt.
A second scenario: when the cap makes all the difference
Let me walk you through a different angle that shows why the valuation cap matters more than most founders realize. Three angel investors approached a founder, collectively offering $400K in convertible notes for equal slices. All three notes had the same terms: $4M valuation cap, 20% discount, 6% interest, and a 24-month maturity.
The founder didn't think to negotiate the cap. It was proposed, it sounded reasonable given the stage, and he signed.
Fourteen months later, a Series A closed at a $12M pre-money valuation. The VC priced shares at $2.00 per share (calculated from the pre-money valuation and post-money expectation).
Now the conversion math: the cap-implied price is $1.00 per share (calculated as $4M cap divided by the fully diluted share count using the discount).
The discount implies $1.60 per share (20% off the $2.00 Series A price).
The investor uses the lower price: $1.00 per share.
Each $100K note converts into 100,000 shares.
Aggregate: 300,000 shares from the three angel notes.
If the founder had negotiated the cap down to $3M instead, the cap-implied price would be $0.75 per share, and each note would convert to 133,333 shares (using the discount, which is now better for the investor but worse for the founder's dilution).
The aggregate from all three notes would be 400,000 shares instead of 300,000. That's 100,000 more shares the angels own, and correspondingly, the founder owns 2.3 percentage points less equity in the company.
Here's the real insight: by standing firm on the $4M cap instead of accepting the investor's initial suggestion of $3M, the founder saved 2.3 percentage points of equity. At a $12M Series A, that's equivalent to saving roughly $300K in founder ownership value. That one negotiation on the cap, done upfront, mattered enormously.
Convertible notes vs. SAFEs: which should you use?
This is the decision tree most founders get wrong. For the legal-side primer, see the overview of convertible securities and SAFE primer. For the full mechanics of how SAFEs convert at a priced round, see our SAFE conversion calculator guide.
A SAFE is not a note. It's a warrant-like agreement. It has no maturity date, no interest, and no repayment obligation.
It's purely a conversion agreement: "If you raise money later, this SAFE converts into stock." A convertible note is actual debt with maturity, interest, and a repayment obligation.
Here's the comparison:
Dimension | Convertible Note | SAFE | Priced Equity |
|---|---|---|---|
Debt or equity? | Debt (until conversion) | Neither | Equity |
Maturity date? | Yes (typically 24-36 months) | No | N/A |
Interest accrual? | Yes (3-8% typical) | No | N/A |
Repayment if no event? | Yes, you owe the principal | No | N/A |
Conversion valuation cap? | Yes | Yes | N/A |
Conversion discount? | Usually yes | Yes | N/A |
Conversion trigger? | Priced round, merger, IPO | Priced round, merger, IPO | Automatic (already stock) |
Founder simplicity? | Low (legal docs, interest tracking) | High (lightweight agreement) | Low (board seats, governance) |
Investor protection | Medium-high (debt status, interest) | Low (essentially gamble on conversion) | Highest (defined rights, preferences) |
Lawyer cost | $3K-$8K | $500-$2K | $5K-$15K (if done right) |
When to use | Bridge rounds, international, debt fundraising | Pre-seed, speed, when SAFE is available | When valuation negotiation is necessary |
The market has shifted hard toward SAFEs in pre-seed. 90% of pre-seed rounds in 2025 used SAFEs. Convertible notes are now mostly used for bridge financing (between Series A and B), international rounds (where SAFEs aren't recognised), or by founders who specifically want debt-style terms.
The founder question: should you use a convertible note? Only if:
You need bridge financing and the maturity discipline matters
You're raising internationally and SAFE legal recognition is weak
You want explicit interest incentives to convert faster
The investor specifically demands debt-style terms (less common now).
In most US pre-seed and seed rounds, a SAFE is simpler, cheaper, faster. Use that instead. But if you're in a bridge round, an international raise, or a revenue-generating company that wants to structure debt, convertible notes are still relevant.
Common founder mistakes with convertible notes (and how to avoid them)
I see patterns repeat across founders. For a foundational primer, the overview of convertible bonds covers the parent instrument that startup convertible notes inherit from. If you're modeling cap table impact across multiple instruments, our cap table management guide covers the dilution math.
Mistake 1: Raising multiple convertible notes without understanding aggregate dilution.
Founders raise $200K in convertible notes from investor A, then $150K from investor B (3 months later, at a different cap), then $100K from investor C (6 months later, at yet another cap).
When a priced Series round closes at a single valuation, all three notes convert at different terms. The founder's cap table math becomes nightmarish. The aggregate dilution is often 10-15% higher than the founder expected, because each note's cap created a slightly different conversion outcome.
The fix: before raising a second convertible note, model the conversion impact at a realistic Series A valuation. Most founders don't do this. They should.
Spreadsheet it out. See what happens when all three notes convert. That's your true dilution.
Mistake 2: Ignoring the maturity date.
Founders sign a convertible note with a 24-month maturity, then assume a Series A will close by then.
Markets shift. Fundraising takes longer.
Month 24 hits. No Series A. Now you owe the principal back.
Most founders don't have cash on hand to repay it. They're forced into a difficult negotiation with the noteholder: extend the maturity, convert it anyway (at what terms?), or face default.
The fix: don't assume a Series A will happen by the maturity date.
If you're in a capital-intense business or a down market, model what happens if maturity hits without a priced round
Plan the extension or refinancing conversation early.
Mistake 3: Confusing the valuation cap with a valuation floor.
Founders think: "I got a $5M cap, so my company's valuation is at least $5M." No.
The cap is an upper bound on the conversion price. If your Series A is at $3M valuation, the cap doesn't protect you, the cap is irrelevant, and the note converts at the lower valuation. The cap only helps the investor (and costs the founder) when the Series A valuation is higher than the cap.
The fix: understand that the cap is the maximum conversion valuation, not the minimum. If the Series A is lower than the cap, the cap doesn't matter.
Mistake 4: Not negotiating the terms early.
Founders often wait until Series A diligence to learn what their convertible note terms actually mean.
By then, the Series A investor is scrutinizing the terms and asking why the cap is so low or why the discount is so high. The founder should have negotiated these upfront, with the noteholder, when there was more flexibility.
The fix: negotiate the cap and discount with the noteholder when you're fundraising the note, not when you're closing the Series A. A $3M cap versus a $5M cap is a huge difference to dilution, and it should be clear and agreed upfront.
When a founder defaulted to notes and paid the price
I worked with a founder who defaulted to a convertible note simply because it was familiar. She had two angels wanting to invest, and both said, "Just do a convertible note; it's standard."
Neither investor would have objected to a SAFE. A SAFE would have been the simpler choice. But the founder didn't ask.
She signed two $200K convertible notes with a 24-month maturity, $5M cap, and 7% interest. Both investors wanted the optionality.
The maturity dates landed 24 months later, in a down market. Series A conversations had stalled. The company had $150K in the bank but no committed investors.
The noteholders' lawyers sent notices: the principal is due in 60 days. The founder couldn't pay. She initiated emergency conversion negotiations.
The investors, now uncomfortable with the company's trajectory, demanded a lower cap: $2.5M instead of the original $5M. They wanted compensation for the risk. The founder had no negotiating room and accepted.
The conversion at the lower cap cost her 12 percentage points of equity compared to what the original $5M cap would have yielded. The maturity pressure forced an unfavorable conversion in a down market. A SAFE would have had no maturity date, no pressure, no emergency negotiation.
The post-2023 reset taught her that defaulting to instruments because they're familiar is expensive. She now uses SAFEs for all pre-seed and seed rounds, unless the investor explicitly requires debt-style terms. The cost of that one wrong choice: roughly $1.2M in founder equity at a future $50M exit.
When should you raise a convertible note?
The decision framework is simpler than most founders think.
Raise a convertible note if:
Bridge rounds (Series A to B). The bridge note converts into Series B stock.
This is the most common use case now. You need speed, and a SAFE doesn't fit the financial structure you want.
Typical bridge rounds have 12-18 month maturities
And higher interest rates (6-8%) to compensate investors for the bridge risk.
International fundraising where SAFEs aren't standard.
SAFEs aren't recognized in UK law, German law, or Singapore law. A convertible note is debt, and debt is recognized everywhere.
A UK founder raising from London-based angels needs a convertible note, not a SAFE, because UK counsel won't opine on a SAFE's enforceability.
German GmbH structures often require debt instruments for tax and accounting reasons.
A Singapore founder raising from local VCs faces similar friction with SAFEs.
In these jurisdictions, convertible notes are still the path of least resistance.
Revenue-generating or break-even companies raising strategic debt.
If you're generating revenue and want to keep founder ownership high, a convertible note lets you structure capital as debt, not equity. You pay interest (which is tax-deductible), and the note converts only when a priced round happens. Some founders prefer this to diluting themselves immediately with equity.
A SaaS company with $50K monthly recurring revenue can credibly offer convertible debt with 5-7% interest, and investors get paid back if the company stabilizes without needing to raise equity.
Corporate or strategic investors requiring debt-style instruments.
A strategic corporate investor (e.g., a potential acquirer or partner) may need to structure their investment as debt for accounting and legal reasons. A convertible note fits this requirement.
Equity might trigger consolidation rules or balance sheet implications that complicate the relationship.
Debt is cleaner for their finance team.
These investors rarely care about the conversion mechanic; they care about getting a defined return until conversion.
You need maturity, discipline and conversion incentives.
A SAFE is frictionless but has zero maturity pressure. If you want to force a Series A timeline or create urgency around fundraising, a convertible note's maturity date and accruing interest do that. Some founders use this intentionally.
When NOT to raise a convertible note:
You're in a pre-seed and SAFEs are available.
Just use a SAFE. It's simpler, cheaper, faster. The market has moved decisively toward SAFEs for pre-seed.
You've already raised multiple convertible notes and understand your aggregate dilution.
Taking a third one adds cap table complexity for marginal benefit. Most founders shouldn't have more than two convertible notes outstanding at once.
You're in a Series A and the investor is asking for equity terms.
Don't bridge with a convertible note. Close the Series A or keep raising pre-seed SAFEs.
Valuation caps and discounts: the economics of investor reward
The cap and the discount are the investor's downside protection and reward for early risk.
The valuation cap is straightforward: the investor's conversion valuation is capped at a maximum.
If the Series A is higher, the cap wins (for the investor).
If it's lower, the actual Series A valuation wins.
The discount is similar: the investor gets shares at a discount to the Series A price. Both structures reward early investors, they get more shares for the same capital.
Here's where it gets tricky: the cap and discount work together. If you have a $5M cap and a 20% discount, and the Series A prices the company at $10M at $10/share, then the cap implies $5/share (price at $5M valuation) and the discount implies $8/share (20% off $10/share). The investor uses the lower of the two: $5/share.
So both the cap and the discount need to be negotiated. A low cap and a high discount are both costly to the founder. Typical market ranges in 2026:
Seed rounds $3M-$8M caps
15-25% discounts.
Bridge rounds:
$10M-$25M caps (typical in 2025-2026)
With 10-15% discounts.
Interest rates:
3-6% for seed
5-8% for bridge
These vary by market, founder credibility, and fundraising environment. In a down market, investors demand lower caps and higher discounts.
Convertible notes and your cap table: planning for conversion
This is where the real complexity lives.
You raised a $150K convertible note in month 3 with a $3M cap. You raised a $100K note in month 8 with a $4M cap.
You raised a $50K note in month 14 with a $5M cap. Your Series A closes in month 20 at $10M post-money. Now what?
All three notes convert into shares. Each at a different cap-implied price. The aggregate dilution is not 3 times a single note's dilution; it's the sum of all three, adjusted for their different caps.
Note 1: Principal $150K, cap $3M.
Note 2: Principal $100K, cap $4M.
Note 3: Principal $50K, cap $5M. Each calculates shares based on its own cap-implied price per share.
The Series A investor sees this cap table complexity and sometimes pushes back. They ask: why are there three notes with three different terms?
This slows diligence. It complicates cap table forecasting. It raises questions.
The fix: before raising a second convertible note, calculate the combined dilution impact.
Model the Series A scenario. Know what your cap table will look like.
To avoid cap table chaos, consider:
Consolidating multiple notes into a single amended agreement with unified terms
Limiting the number of convertible notes to one or two maximum
Using a spreadsheet to model conversion outcomes at realistic Series A valuations
Discussing cap table impact with potential Series A investors before closing the note
Personal assessment: what I see most
Three weeks ago, a B2B SaaS founder called with a $1.2M Series A lead offer on the table. They'd raised $200K in convertible notes from three angels, each with different caps ranging from $3M to $5M. The Series A partner wanted to lead at $8M post-money, but the lead investor's lawyer flagged the multiple note conversions during diligence.
The founder had never modeled what those three notes would become at $8M valuation. I ran the math: aggregate founder dilution was 3.2 percentage points higher than if they'd used a single SAFE or kept just one note. They were sitting on $255K in unmodeled equity loss.
I told them: "Go back to your angel investors and see if you can consolidate the $200K into a single $3.5M cap note with 20% discount. The math gets cleaner for the Series A investor, you save $255K in equity, and your Series A process accelerates." They negotiated the consolidation. The Series A closed 60 days later.
No diligence friction over cap table mess. That's the real difference between modeling upfront and defaulting to instruments because they feel familiar. Founders accept convertible note terms because investors prefer them, not because the math actually protects founder optionality.
They were standard in 2017-2019. In 2026, they're a deliberate choice, not a default path. For broader fundraising context, YC's seed fundraising guide walks through how convertible notes fit into the early-stage process.
The cleanest convertible notes I see are the boring ones: standard cap, standard discount, six percent interest, two-year maturity, no Most-Favored-Nation clause, no redemption rights. The messy ones come from founders who want to feel sophisticated.
Be boring with notes. Save sophistication for the priced round.
What I see most: founders who raise a convertible note, then are surprised when the Series A investor scrutinizes the terms and asks why the cap is so low. They didn't negotiate it properly upfront.
They didn't model the dilution impact. They didn't think it through.
And then they're in Series A diligence, and the cap table looks worse than they expected. My advice: if you're considering a convertible note, spend 2 hours upfront modelling the conversion math. Get the cap and discount right.
Understand your maturity date and what happens if Series A doesn't close by then. Then make the decision: convertible note or SAFE? In most cases, SAFE wins.
How spectup helps?
A SaaS founder came to us in February 2026 with a bridge round term sheet: $800K convertible note at $12M cap, 6% interest, 18-month maturity. She was uncertain about the cap's impact on her existing cap table, which already had two earlier seed notes outstanding.
We modeled the conversion outcomes across three realistic Series B scenarios ($15M, $20M, $25M valuations). The $12M cap created 7.1% more dilution than a $14M cap would have.
She renegotiated with her lead investor and moved the cap to $13.5M, saving approximately $180K in founder ownership value at a projected $30M Series B exit. The deal closed in March.
If you're raising capital and trying to choose between a convertible note, a SAFE, or priced equity, the decision matters. spectup's fundraising consultant team helps founders work through these choices through structured capital advisory.
The structure you choose cascades through your entire cap table and future fundraises. After running 150+ capital raises, I've seen the cap table nightmare that starts with a poorly negotiated convertible note.
The founder didn't model the dilution. The pitch deck services we offer cover this exact gap.
The Series A investor questioned the terms. Diligence slowed. The round nearly died over cap table complexity that could've been prevented with 2 hours of upfront math.
For sample term language, Cooley GO maintains a convertible note glossary entry and the term sheet primer covers the surrounding deal architecture.
That's where structure matters. A fundraising consultant who's sat through 100 convertible note conversions sees the patterns.
They know the caps and discounts that are market, and which ones are aggressive. They know what happens when you stack multiple notes.
If you're six to twelve months from a Series A and want to understand your current cap table risk or need financial modeling support for bridge financing, or you're considering bridge financing and want to model the impact before signing, book a call with me.
Concise Recap: Key Insights
Debt with conversion mechanics, not equity shortcuts.
Convertible notes have maturity dates, interest rates, and repayment obligations. They're not simpler than equity, they're just cheaper for the founder upfront, with costs deferred to Series A conversion.
Negotiate caps and discounts upfront, not at Series A diligence.
A $3M cap versus a $5M cap creates 10-15% more founder dilution at conversion. These terms are locked once you sign. Model them before you commit.
Multiple notes create aggregate dilution that founders miss.
When three convertible notes with different caps all convert at Series A, the combined dilution is often higher than expected. Calculate the full impact before raising the second note.
Frequently Asked Questions
What happens if my startup fails before the convertible note converts?
If you fail and shut down, the convertible noteholder is treated as a creditor, not a stockholder. They have a claim on the company's remaining assets, junior to bank debt but senior to equity holders. In practice, most startup failures have zero assets left, so noteholders rarely recover anything.
